ResiRole: residue-level functional site predictions to gauge the accuracies of protein structure prediction techniques von Toth, Joshua M, DePietro, Paul J, Haas, Juergen, McLaughlin, William A

Volltext

Clinical and Biologic Correlates of ADORA2A Transcriptomic Expression in Cancer von Shreenivas, Aditya, Nishizaki, Daisuke, Lee, Suzanna, Pabla, Sarabjot, Nesline, Mary, Conroy, Jeffrey M, DePietro, Paul, Kato, Shumei, Kurzrock, Razelle

Volltext

A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumors von Conroy, Jeffrey M, Pabla, Sarabjot, Glenn, Sean T, Seager, R J, Van Roey, Erik, Gao, Shuang, Burgher, Blake, Andreas, Jonathan, Giamo, Vincent, Mallon, Melissa, Lee, Yong Hee, DePietro, Paul, Nesline, Mary, Wang, Yirong, Lenzo, Felicia L, Klein, Roger, Zhang, Shengle

Volltext

The Pharmacorank Search Tool for the Retrieval of Prioritized Protein Drug Targets and Drug Repositioning Candidates According to Selected Diseases von Gnilopyat, Sergey, DePietro, Paul J, Parry, Thomas K, McLaughlin, William A

Volltext

LAG‐3 transcriptomic expression patterns across malignancies: Implications for precision immunotherapeutics von Adashek, Jacob J., Kato, Shumei, Nishizaki, Daisuke, Miyashita, Hirotaka, De, Pradip, Lee, Suzanna, Pabla, Sarabjot, Nesline, Mary, Conroy, Jeffrey M., DePietro, Paul, Lippman, Scott, Kurzrock, Razelle

Volltext

Cancer testis antigen burden (CTAB): a novel biomarker of tumor-associated antigens in lung cancer von Seager, R J, Senosain, Maria-Fernanda, Van Roey, Erik, Gao, Shuang, DePietro, Paul, Nesline, Mary K, Dash, Durga Prasad, Zhang, Shengle, Ko, Heidi, Hastings, Stephanie B, Strickland, Kyle C, Previs, Rebecca A, Jensen, Taylor J, Eisenberg, Marcia, Caveney, Brian J, Severson, Eric A, Ramkissoon, Shakti, Conroy, Jeffrey M, Pabla, Sarabjot

Volltext

High CTLA-4 transcriptomic expression correlates with high expression of other checkpoints and with immunotherapy outcome von Krishnamurthy, Nithya, Nishizaki, Daisuke, Lippman, Scott M, Miyashita, Hirotaka, Nesline, Mary K, Pabla, Sarabjot, Conroy, Jeffrey M, DePietro, Paul, Kato, Shumei, Kurzrock, Razelle

Volltext

Pan‐cancer analysis of TIM‐3 transcriptomic expression reveals high levels in pancreatic cancer and interpatient heterogeneity von Lim, Jungah, Kurzrock, Razelle, Nishizaki, Daisuke, Miyashita, Hirotaka, Adashek, Jacob J., Lee, Suzanna, Pabla, Sarabjot, Nesline, Mary, Conroy, Jeffrey M., DePietro, Paul, Lippman, Scott M., Kato, Shumei

Volltext

T-cell priming transcriptomic markers: implications of immunome heterogeneity for precision immunotherapy von Miyashita, Hirotaka, Kurzrock, Razelle, Bevins, Nicholas J., Thangathurai, Kartheeswaran, Lee, Suzanna, Pabla, Sarabjot, Nesline, Mary, Glenn, Sean T., Conroy, Jeffrey M., DePietro, Paul, Rubin, Eitan, Sicklick, Jason K., Kato, Shumei

Volltext

4‐1BB transcriptomic expression patterns across malignancies: Implications for clinical trials of 4‐1BB agonists von Uehara, Yuji, Kato, Shumei, Nishizaki, Daisuke, Miyashita, Hirotaka, Lee, Suzanna, Nesline, Mary K., Pabla, Sarabjot, Conroy, Jeffrey M., DePietro, Paul, Ko, Heidi, Sicklick, Jason K., Kurzrock, Razelle

Volltext

High indoleamine 2,3-dioxygenase transcript levels predict better outcome after front-line cancer immunotherapy von Fujiwara, Yu, Kato, Shumei, Nishizaki, Daisuke, Miyashita, Hirotaka, Lee, Suzanna, Nesline, Mary K., Conroy, Jeffrey M., DePietro, Paul, Pabla, Sarabjot, Lippman, Scott M., Kurzrock, Razelle

Volltext

The Impact of Prior Single-Gene Testing on Comprehensive Genomic Profiling Results for Patients with Non-Small Cell Lung Cancer von Nesline, Mary K., Subbiah, Vivek, Previs, Rebecca A., Strickland, Kyle C., Ko, Heidi, DePietro, Paul, Biorn, Michael D., Cooper, Maureen, Wu, Nini, Conroy, Jeffrey, Pabla, Sarabjot, Zhang, Shengle, Wallen, Zachary D., Sathyan, Pratheesh, Saini, Kamal, Eisenberg, Marcia, Caveney, Brian, Severson, Eric A., Ramkissoon, Shakti

Volltext

166 High CTLA-4 transcriptomic expression correlates with high expression of other checkpoints and with outcome on immune checkpoint inhibitors von Krishnamurthy, Nithya, Nishizaki, Daisuke, Lippman, Scott M, Miyashita, Hirotaka, Nesline, Mary K, Pabla, Sarabjot, Conroy, Jeffrey M, DePietro, Paul, Kato, Shumei, Kurzrock, Razelle

Volltext

Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response von Pabla, Sarabjot, Seager, R J, Van Roey, Erik, Gao, Shuang, Hoefer, Carrie, Nesline, Mary K, DePietro, Paul, Burgher, Blake, Andreas, Jonathan, Giamo, Vincent, Wang, Yirong, Lenzo, Felicia L, Schoenborn, Margot, Zhang, Shengle, Klein, Roger, Glenn, Sean T, Conroy, Jeffrey M

Volltext

65 PD-L1 by RNA next generation sequencing: comparison with PD-L1 IHC 22C3 and association with survival benefit from pembrolizumab with or without chemotherapy in non-small cell l... von Lee, Yong Hee, Dy, Grace, DePietro, Paul, Conroy, Jeffrey, Pabla, Sarabjot, Nesline, Mary

Volltext

O09: Potential germline variants are frequently identified when performing comprehensive genomic profiling of solid tumors von Jensen, Taylor, Noeth, Dagny, Cronister, Amy, DePietro, Paul, Klein, Roger, Nesline, Mary, Pabla, Sarabjot, Chenn, Anjen, Zhang, Shengle, Klein, Jonathan, Howarth, Sarah, Severson, Eric, Ramkissoon, Shakti, Eisenberg, Marcia, Reddy, Prasanth, Conroy, Jeffrey

Volltext

77 Prevalence of secondary immunotherapeutic targets in the absence of established immune biomarkers in solid tumors von DePietro, Paul, Nesline, Mary, Lee, Yong Hee, Seager, RJ, Roey, Erik Van, Gao, Shuang, Giamo, Vincent, Burgher, Blake, Glenn, Sean, Zhang, Shengle, Klein, Roger, Pabla, Sarabjot, Conroy, Jeffrey

Volltext

70 Novel immunotherapeutic targets in cancer of unknown primary (CUP) von Nesline, Mary, DePietro, Paul, Lee, Yong Hee, Bliss, Zachery, Seager, RJ, Roey, Erik Van, Gao, Shuang, Giamo, Vincent, Burgher, Blake, Glenn, Sean, Zhang, Shengle, Pabla, Sarabjot, Klein, Roger, Conroy, Jeffrey

Volltext

80 Cancer testis antigen burden: A novel predictive biomarker for immunotherapy in solid tumors von Pabla, Sarabjot, Seager, RJ, Lee, Yong Hee, Roey, Erik Van, Gao, Shuang, Giamo, Vincent, Burgher, Blake, DePietro, Paul, Nesline, Mary, Glenn, Sean, Zhang, Shengle, Conroy, Jeffrey

Volltext

Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy von Fujiwara, Yu, Kato, Shumei, Nesline, Mary K, Conroy, Jeffrey M, DePietro, Paul, Pabla, Sarabjot, Kurzrock, Razelle

Volltext